Serum level of soluble intercellular adhesion molecule 1 in patients with chronic liver disease related to hepatitis C virus: A prognostic marker for responses to interferon treatment

Journal of Infectious Diseases

Volumn 181, Issue 2, 2000, Pages 425-431

  Capra, Franco ^a   De Maria, Elena ^a   Lunardi, Claudio ^a   Marchiori, Luigi ^a   Mezzelani, Paolo ^a   Beri, Ruggero ^a   Gabrielli, Giovanni Battista ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON ALFA-2A; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034049480     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315265     Document Type: Article

References (35)

1. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
2. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991;338:83-4.
3. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 1987;51:813-9.
4. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of intercellular adhesion molecule 1 (ICAM-1) demonstrates interaction between members of the Ig and integrin supergene families. Cell 1988;52:925-33.
5. Horiike N, Onji M, Kumon I, Kanaoka M, Michitaka K, Ohta Y. Intercellular adhesion molecule-1 expression on the hepatocyte membrane of patients with chronic hepatitis B and C. Liver 1993;13:10-4.
6. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788-93.
7. Simpson KJ, Hayes PC. Soluble adhesion molecules in immune mediated liver disease. Gut 1995;36:806-8.
8. Adams DH, Mainolfi E, Burra P, et al. Detection of circulating intercellular adhesion molecule-1 in chronic liver disease. Hepatology 1992;16:810-4.
9. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-12.
10. Hyodo I, Jinno K, Tanimizu M, et al. Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma. Int J Cancer 1993;55:775-9.
11. Nouri-Aria KT, Koskinas J, Tibbs CJ, Portmann BC, Williams R. Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferon α. Gut 1995;36:599-603.
12. Volpes R, Van Den Oord JJ, Desmet VY. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990;12:59-65.
13. Garcia-Monzon C, Garcia-Buey L, Garcia-Sanchez A, Pajares JM, Moreno- Otero R. Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon α-2b. Gastroenterology 1993;105:462-9.
14. Zohrens G, Armbrust T, Pirzer U, Meyer zum Buschenfelde KH, Ramadori G. Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis. Hepatology 1993;18:798-802.
15. Yang SS, Tsai G, Wu CH, Chen DS. Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis. Hepatogastroenterology 1996;43:575-81.
16. Lim AG, Jazrawi RP, Ahamed HA, et al. Soluble intercellular adhesion molecule 1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis. Hepatology 1994;20:882-8.
17. Douds AC, Lim AG, Jazrawi RP, Finlayson C, Maxwell JD. Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity. J Hepatol 1997;26:280-6.
18. Bagnasco M, Riccio AM, Sinelli M, et al. Serum intercellular adhesion molecule-1 and long-term response to IFN-α-2B therapy in chronic hepatitis C. J Interferon Cytokine Res 1998;18:963-6.
19. Lo Iacono O, Garcia Monzon C, Almasio P, Garcia Buey L, Craxi A, Moreno Otero R. Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon α. Aliment Pharmacol Ther 1998;12:1091-9.
20. Di Bisceglie AM. Hepatitis C. Lancet 1998;351:351-5.
21. EASL International consensus conference on hepatitis C. Paris, 26-28 February 1999. Consensus statement. J Hepatol 1999;30:956-61.
22. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probes assay. J Gen Virol 1993;74:1093-1102.
23. Giannini C, Thiers V, Nousbaum JB, Stuyver L, Maertens G, Brechot C. Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes. J. Hepatol 1995;23:246-53.
24. Simmonds P, Mc Omish F, Yap PL, et al. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restriction on sequence diversity. J Gen Virol 1993;74:661-8.
25. Scheuer P, Maggi G. Hepatic fibrosis and collapse histological distinction by orcein staining. Histopatology 1980;4:487-90.
26. International Group. Acute and chronic hepatitis revisited. Lancet 1977;2:914-9.
27. Scheuer P. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-4.
28. Gabrielli GB, Capra F, Casaril M, et al. Serum laminin and type III procollagen in chronic hepatitis C: diagnostic value in the assessment of disease activity and fibrosis. Clin Chim Acta 1997;265:21-31.
29. National Institutes of Health Consensus Development Conference Panel Statement. Management of hepatitis C. Hepatology 1997;26(Suppl):2S-10S.
30. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
31. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-9.
32. Banner BF, Allan C, Savas L, Baker S, Barnard G, Bonkovsky HL. Inflammatory markers in chronic hepatitis C. Virchows Arch 1997;431:181-7.
33. Garcia-Monzon C, Sanchez-Madrid R, Garcia-Buey L, et al. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 1995;108:231-41.
34. Taliani G, Badolato MC, Bozza A, et al. HCV infection of peripheral blood mono nuclear cells and serum levels of soluble ICAM-1 in patients treated with interferon. Arch Virol 1997;142:557-65.
35. Shimizu Y, Minemura M, Tsukishiro T, et al. Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology 1995;22:525-31.